Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Paper
  • Published:

Role of zinc in the pathogenesis and treatment of prostate cancer: critical issues to resolve

Prostate Cancer and Prostatic Diseases volume 7, pages 111–117 (2004)Cite this article

Abstract

The most consistent and persistent biochemical characteristic of prostate cancer (PCa) is the marked decrease in zinc and citrate levels in the malignant cells. This relationship provides compelling evidence that the lost ability of the malignant cells to accumulate zinc is an important factor in the development and progression of prostate malignancy. In addition, this relationship provides a rational basis for the concept that restoration of high zinc levels in malignant cells could be efficacious in the treatment and prevention of PCa. Epidemiological studies regarding dietary zinc effects on PCa have been conflicting and confusing. The purpose of this presentation is to present a current state of information regarding zinc relationships in the pathogenesis and treatment of PCa. We also hope to bring more attention to the medical and research community of the critical need for concerted clinical and basic research regarding zinc and PCa.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5

Similar content being viewed by others

References

  1. Costello LC, Franklin RB . The novel role of zinc in the intermediary metabolism of prostate epitelial cells and its implications in prostate malignancy. Prostate 1998; 35: 285–296.

    Article  CAS  Google Scholar 

  2. Costello LC, Franklin RB . The intermediary metabolism of the prostate: a key to understanding the pathogenesis and progression of prostate malignancy. Oncology 2000; 59: 269–282.

    Article  CAS  Google Scholar 

  3. Costello LC, Franklin RB . The metabolism of prostate malignancy: insights into the pathogenesis of prostate cancer and new approaches for its diagnosis and treatment. Oncol Spectr 2001; 2: 452–457.

    Google Scholar 

  4. Costello L, Franklin RB, Kurhanewicz J . The metabolic characterization of prostate malignancy by magnetic resonance spectroscopy. In: Encyclopedia of Cancer. Academic Press: New York, 2002; 2nd edition 3: 167–177.

    Chapter  Google Scholar 

  5. Costello LC, Franklin RB, Narayan P . Citrate in the diagnosis of prostate cancer. Prostate 1999; 38: 237–245.

    Article  CAS  Google Scholar 

  6. Costello LC, Liu Y, Franklin RB, Kennedy MC . Zinc inhibition of mitochondrial aconitase and its importance in citrate metabolism of prostate epithelial cells. J Biol Chem 1997; 272: 28875–28881.

    Article  CAS  Google Scholar 

  7. Feng P et al. Direct effect of zinc on mitochondrial apoptogenesis in prostate cells. Prostate 2002; 52: 311–318.

    Article  CAS  Google Scholar 

  8. Feng P et al. Zinc induces mitochondria apoptogenesis in prostate cells. Mol Urol 2002; 4: 31–35.

    Google Scholar 

  9. Liang JY et al. Inhibitory effect of zinc on human prostatic carcinoma cell growth. Prostate 1999; 40: 200–207.

    Article  CAS  Google Scholar 

  10. Costello LC, Liu Y, Zou J, Franklin RB . Evidence for a zinc uptake transporter in human prostate cancer cells which is regulated by prolactin and testosterone. J Biol Chem 1999; 274: 17499–17504.

    Article  CAS  Google Scholar 

  11. Franklin RB et al. hZIP1 is a major zinc uptake transpoter for the accumulation of zinc in prostate cells. J Inorg Biochem 2003; 96: 435–442.

    Article  CAS  Google Scholar 

  12. Rishi I et al. Prostate cancer in African-American men is associated with down-regulation of zinc transporters. App Immunohistochem Mol Morph 2003; 11: 253–260.

    Article  CAS  Google Scholar 

  13. Zaichick VY, Sviridova TV, Zaichick SV . Zinc in the human prostate gland: normal, hyperplastic, cancerous. Int Urol Nephr 1997; 29: 565–574.

    Article  Google Scholar 

  14. Liney GP et al. In vitro quantification of citrate concentration and water T2 relaxation time of the pathologic prostate gland using 1H MRS and MRI. Mag Reson Imag 1997; 15: 1177–1186.

    Article  CAS  Google Scholar 

  15. Cooper JE, Farid I . The role of citric acid in the physiology of the prostate. Lactic/citrate ratios in benign and malignant prostatic homogenates as an index of prostatic malignancy. J Urol 1964; 92: 533–536.

    Article  CAS  Google Scholar 

  16. Habib FK, Mason MK, Smith PH, Stitch SR . Cancer of the prostate: early diagnosis by zinc and hormone analysis. Br J Cancer 1979; 39: 700–704.

    Article  CAS  Google Scholar 

  17. Mocchegiani E, Muaaioli M, Giacconi R . Zinc, metallothioneins, immune responses, survival and ageing. Biogeront 2000; 1: 133–143.

    Article  CAS  Google Scholar 

  18. Feustel A, Wenrich R . Zinc and cadmium plasma and erythrocyte levels in prostatic carcinoma, BPH, urological malignancies, and inflammation. Prostate 1986; 8: 75–79.

    Article  CAS  Google Scholar 

  19. Whelan P, Walker BE, Kelleher J . Zinc, vitamin A, and prostate cancer. Br J Urol 1983; 55: 525–528.

    Article  CAS  Google Scholar 

  20. Ogunlewe JO, Osegbe DN . Zinc and cadmium concentrations in indigenous blacks with normal, hypertrophic, and malignant prostate. Cancer 1989; 63: 1388–1392.

    Article  CAS  Google Scholar 

  21. Liu Y, Costello LC, Franklin RB . Prolactin and testosterone regulation of mitochondrial zinc in prostate epithelial cells. Prostate 1997; 30: 26–32.

    Article  CAS  Google Scholar 

  22. Feng P et al. Effect of zinc on prostatic tumorigenicity in nude mice. Ann N Y Acad Sci 2003; 1010: 316–320.

    Article  CAS  Google Scholar 

  23. Leitzmann MF et al. Zinc supplement use and risk of prostate cancer. J Natl Cancer Inst 2003; 95: 1004–1007.

    Article  CAS  Google Scholar 

  24. Kristal AR et al. Vitamin and mineral supplement use is associated with reduced risk of prostate cancer. Cancer Epidemiol Biomark Prevent 1999; 8: 887–892.

    CAS  Google Scholar 

  25. Key TJA et al. A case–control study of diet and prostate cancer. Br J Cancer 1997; 76: 678–687.

    Article  CAS  Google Scholar 

  26. West DW et al. Adult dietary intake and prostate cancer risk in Utah: a case–control study with special emphasis on aggressive tumors. Cancer Causes Control 1991; 2: 85–94.

    Article  CAS  Google Scholar 

  27. Andersson SO et al. Energy, nutrient intake and prostate cancer risk: a population-based case–control study in Sweden. Int J Cancer 1996; 68: 716–722.

    Article  CAS  Google Scholar 

  28. Vlajinac HD, Marinkovic JM, Ilic MD, Kocev NI . Diet and prostate cancer: a case–control study. Eur J Cancer 1997; 33: 101–107.

    Article  CAS  Google Scholar 

  29. Kolonel LN, Yoshizawa CN, Hankin JH . Diet and prostatic cancer: a case–control study in Hawaii. Am J Epidemiol 1988; 127: 999–1012.

    Article  CAS  Google Scholar 

  30. Thomas JA . Diet, micronutrients and the prostate gland. Nutr Rev 1999; 4: 95–103.

    Google Scholar 

  31. Platz EA, Helzlsouer KJ . Selenium, zinc, and prostate. Epidemiol Rev 2001; 23: 93–101.

    Article  CAS  Google Scholar 

  32. Kolonel LN . Nutrition and prostate cancer. Cancer Causes Control 1996; 7: 83–94.

    Article  CAS  Google Scholar 

  33. Lonnerdal B . Dietary factors influencing zinc absorption. J Nutr 2000; 130: 1378S–1383S.

    Article  CAS  Google Scholar 

  34. Krebs NF . Overview of zinc absorption and excretion in the human gastrointestinal tract. J Nutr 2000; 130: 1374S–1377S, J Nutr 2000; 130:1360S–1366S.

    Article  CAS  Google Scholar 

  35. King JC, Shames DM, Woodhouse LB . Zinc homeostasis in humans. J Nutr 2000; 130: 1360S–1366S.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The studies of the authors contained in this presentation were supported by NIH Grants DK42839, CA71207, CA79903, CA93443 and by DOD Grant DAMD 17-01-1-0072.

Author information

Authors and Affiliations

  1. Department of Biomedical Sciences, Dental School, University of Maryland, Baltimore, Maryland, USA

    L C Costello, P Feng, B Milon & R B Franklin

  2. Division of Biostatistics, Greenebaum Cancer Center, University of Maryland, Baltimore, Maryland, USA

    M Tan

Authors
  1. L C Costello
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. P Feng
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. B Milon
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. M Tan
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. R B Franklin
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to L C Costello.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Costello, L., Feng, P., Milon, B. et al. Role of zinc in the pathogenesis and treatment of prostate cancer: critical issues to resolve. Prostate Cancer Prostatic Dis 7, 111–117 (2004). https://doi.org/10.1038/sj.pcan.4500712

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.pcan.4500712

Keywords

This article is cited by

Search

Advanced search

Quick links